![Arjan W. Griffioen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Posizioni attive di Arjan W. Griffioen
Società | Posizione | Inizio | Fine |
---|---|---|---|
PepTx, Inc. | Fondatore | 09/06/2011 | - |
CimCure BV
![]() CimCure BV Miscellaneous Commercial ServicesCommercial Services CimCure BV is a Dutch new generation company founded in 2015 as a spin-off of the VU University Medical Center. CimCure is based in Amsterdam, Netherlands. The company focuses on the design and development of a novel class of active cancer vaccines that target the tumor blood vessels common to most solid tumors. CimCure has discovered and patented multiple highly specific targets and a novel conjugate vaccine technology that can induce polyclonal antibody responses to targets specific to the tumor vasculature. The company aims to combine the proven efficacy of tumor angiogenesis inhibition with the advantages that a vaccine may provide. The company was founded in 2015 by Arjan W. Griffioen, and Diederik Engbersen has been the CEO of the company since 2020. | Direttore Tecnico/Scientifico/R&S | 01/01/2015 | - |
Fondatore | 01/01/2015 | - |
Storia della carriera di Arjan W. Griffioen
Precedenti posizioni note di Arjan W. Griffioen
Società | Posizione | Inizio | Fine |
---|---|---|---|
SomantiX BV
![]() SomantiX BV Miscellaneous Commercial ServicesCommercial Services SomantiX BV develops imaging and therapy of cancer through targeting of tumor blood vessels. The firm offers Somantix’ screening platform which is in combination with the binder generation technologies that allows validation of new therapeutic targets and development of new cancer medicines. The company was founded in 2008 and is headquartered in Utrecht, Netherlands. | Direttore Tecnico/Scientifico/R&S | 09/06/2011 | - |
Statistiche
Distribuzione geografica
Paesi Bassi | 3 |
Stati Uniti | 2 |
Posizioni
Chief Tech/Sci/R&D Officer | 2 |
Founder | 2 |
Settori
Commercial Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 3 |
---|---|
SomantiX BV
![]() SomantiX BV Miscellaneous Commercial ServicesCommercial Services SomantiX BV develops imaging and therapy of cancer through targeting of tumor blood vessels. The firm offers Somantix’ screening platform which is in combination with the binder generation technologies that allows validation of new therapeutic targets and development of new cancer medicines. The company was founded in 2008 and is headquartered in Utrecht, Netherlands. | Commercial Services |
PepTx, Inc. | |
CimCure BV
![]() CimCure BV Miscellaneous Commercial ServicesCommercial Services CimCure BV is a Dutch new generation company founded in 2015 as a spin-off of the VU University Medical Center. CimCure is based in Amsterdam, Netherlands. The company focuses on the design and development of a novel class of active cancer vaccines that target the tumor blood vessels common to most solid tumors. CimCure has discovered and patented multiple highly specific targets and a novel conjugate vaccine technology that can induce polyclonal antibody responses to targets specific to the tumor vasculature. The company aims to combine the proven efficacy of tumor angiogenesis inhibition with the advantages that a vaccine may provide. The company was founded in 2015 by Arjan W. Griffioen, and Diederik Engbersen has been the CEO of the company since 2020. | Commercial Services |
- Borsa valori
- Insiders
- Arjan W. Griffioen
- Esperienza